Pharmaceutical News

RSS

Eritoran drug does not reduce risk of death in patients with severe sepsis

Administration of the drug eritoran to patients with severe sepsis and septic shock failed to demonstrate a significant effect on reducing all-cause 28-day mortality or 1-year mortality, compared with placebo, according to a study in the March 20 issue of JAMA.

20 Mar 2013

Toddlers exposed to methamphetamine have abnormal response to stressful situations

Some 2-year-olds whose moms used methamphetamine during pregnancy may have an abnormal response to stressful situations, according to a study in the May issue of the Journal of Studies on Alcohol and Drugs.

20 Mar 2013

Prevalence of acute hepatitis C virus infection is nearly 1% among newly incarcerated inmates

study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates with a history of recent drug use.

20 Mar 2013

Study finds significant variation over diuretics use in BPD patients

Even though there is little data to support the extended use of diuretic medications to help reduce fluid build-up in the lungs of premature infants, researchers at Nationwide Children's Hospital have found significant variation in how babies receive these medications at hospitals across the nation.

20 Mar 2013

SSRI antidepressants taken during pregnancy do not impact infant's growth over the first year

Selective serotonin reuptake inhibitor (SSRI) antidepressants taken by a woman during pregnancy do not impact her infant's growth over the first year, reports a new study from a Northwestern Medicine scientist.

20 Mar 2013

Antagonist drug Emend halts brain tumor growth

New research from the University of Adelaide has shown for the first time that the growth of brain tumors can be halted by a drug currently being used to help patients recover from the side effects of chemotherapy.

20 Mar 2013

Biogen receives additional patent protection for MS drug TECFIDERA

Biogen Idec today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,399,514, which offers additional protection for TECFIDERA (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis.

20 Mar 2013

Nanomedicines prevent tissue damage associated with atherosclerosis, other chronic diseases

Doses of medicine 100,000 times smaller than the diameter of a human hair prevent the tissue damage associated with atherosclerosis and other chronic diseases in mice.

20 Mar 2013

Research findings could lead to development of new drugs for gout treatment

Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout.

20 Mar 2013

Viewpoints: Protect the FDA's regulatory efforts; Generic drug 'shenanigans;' Does Ryan not understand the 2012 election?

On Tuesday, the Supreme Court will hear arguments in Mutual Pharmaceutical v. Bartlett, a case about the ability of consumers to bring lawsuits against the makers of generic drugs.

20 Mar 2013

Spending on prescription drugs dropped slightly in 2012

The decrease was miniscule, but it was the first time since 1957 that the research firm IMS Health had recorded a dip in United States drug expenditures, reports The New York Times. In related news, more effective use of medications could lead to Medicare savings, according to the Congressional Budget Office.

20 Mar 2013

Large population of healthy people take Aspirin to prevent cardiovascular disease: Study

A new study out of the Faculty of Medicine & Dentistry shows a large population of healthy people are taking Aspirin to prevent cardiovascular disease, despite the fact that new literature shows it isn't as beneficial as once thought.

20 Mar 2013

Study: Propofol addiction is a debilitating form of substance dependence

Abuse of the anesthesia drug propofol is a "rapidly progressive form of substance dependence" that is being more commonly seen among health care professionals, reports a study in the April Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

19 Mar 2013

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

19 Mar 2013

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Mylan Inc. today announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levalbuterol Inhalation Solution USP, 0.31 mg/3 mL (0.0103%), 0.63 mg/3 mL (0.021%), and 1.25 mg/3 mL (0.042%), (Concentrate).

19 Mar 2013

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

19 Mar 2013

FDA alert: All sterile drug products of Med Prep Consulting recalled due to contamination

The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of all products produced by Med Prep Consulting Inc. of Tinton Falls, N.J, a specialty pharmacy licensed by the state of New Jersey.

19 Mar 2013

Generic drugmaker liability question to be argued Tuesday before the High Court

The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drugmakers can be held liable for alleged flaws in the designs of their medications, even though federal law requires generic manufacturers to copy the brand drugmaker's design.

19 Mar 2013

BUSM awarded funding to provide opioid prescribing education to health care providers

Awarded the first of its kind funding to provide FDA-mandated opioid prescribing education, Boston University School of Medicine has launched a program to train health care providers how to safely and effectively manage patients with chronic pain using opioid analgesics.

19 Mar 2013

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego.

18 Mar 2013

Pharmaceutical News

Eritoran drug does not reduce risk of death in patients with severe sepsis

Toddlers exposed to methamphetamine have abnormal response to stressful situations

Prevalence of acute hepatitis C virus infection is nearly 1% among newly incarcerated inmates

Study finds significant variation over diuretics use in BPD patients

SSRI antidepressants taken during pregnancy do not impact infant's growth over the first year

Antagonist drug Emend halts brain tumor growth

Biogen receives additional patent protection for MS drug TECFIDERA

Nanomedicines prevent tissue damage associated with atherosclerosis, other chronic diseases

Research findings could lead to development of new drugs for gout treatment

Viewpoints: Protect the FDA's regulatory efforts; Generic drug 'shenanigans;' Does Ryan not understand the 2012 election?

Spending on prescription drugs dropped slightly in 2012

Large population of healthy people take Aspirin to prevent cardiovascular disease: Study

Study: Propofol addiction is a debilitating form of substance dependence

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Mylan gets final approval from FDA for generic Xopenex Inhalation Solution

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

FDA alert: All sterile drug products of Med Prep Consulting recalled due to contamination

Generic drugmaker liability question to be argued Tuesday before the High Court

BUSM awarded funding to provide opioid prescribing education to health care providers

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News